Wednesday, April 15, 2026
wellness India Expo
Home Tags India

Tag: India

Aurigene wins RE Pharma award; contributes to two US FDA Novel...

In a significant milestone year, Aurigene also served as the primary API manufacturer for two of the 46 Novel Drug Approvals granted by the (USFDA) in 2025

Philips and ACTREC Tata Memorial Cancer Centre join hands to strengthen...

Philips Spectral CT 7500 enables clinicians to capture detailed spectral information during routine CT scans

Jubilant Bhartia Foundation & McGill University collaborate to launch CoE in...

This partnership will leverage McGill University’s research led AI ecosystem to create an innovative program that integrates strong theoretical foundations with practical implementation

AbbVie’s $100 billion US deal & FDA reforms highlight growing focus...

Coupled with the evolving US Food and Drug Administration manufacturing reforms, the deal underscores a policy-driven shift

Healthy occupancy, rising realisations to drive 14-15% growth in private hospitals

Bed additions to double; faster ramp-up to aid margins, ensuring that accruals fund bulk of capex

Lupin ranks no. 1 globally in pharma; tops all sectors in...

The company attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally

Congenital Hypothyroidism: A simple newborn test can prevent lifelong intellectual disability

Early diagnosis remains the key to preventing lifelong intellectual disability

MSD appoints Brecht Vanneste as Managing Director of India

Brecht is a biopharmaceutical industry veteran who has been at MSD for more than 27 years, and has held a portfolio of international leadership roles

Advantage Health Care – India 2026: Medical Value Travel acts as...

Advantage Healthcare India 2026 aims to foster patient mobility, knowledge exchange, skill development and institutional partnerships,

Permanent Trustee of Lilavati Trust writes to PM alleging ₹100 Crore...

The letter reportedly includes a written disclosure from the newly appointed Chief Financial Officer, which, according to Mehta, confirms that major financial irregularities were authorised by the accused individuals